|
|
||||||||
Ann Thorac Surg 1996;62:1021-1025
© 1996 The Society of Thoracic Surgeons
Department of Chest Surgery, National Kyushu Cancer Center, Fukuoka, Japan
Accepted for publication May 8, 1996.
Background. Whether any difference exists in clinical characteristics between resected nonsmall cell lung cancer with either skip or ordinary mediastinal lymph node metastases (N2 disease) needs to be clarified.
Methods. There were 110 patients with stage IIIA N2 disease. Thirty-three patients demonstrating no metastasis at the hilar nodes [skip (+) group] were compared with the other 77 patients [skip (-) group]. To investigate the extent of nodal involvement, we classified the mediastinal lymph nodes into three regions (superior, inferior, or aortic).
Results. There were no significant differences regarding histologic type, T status, or the site of the primary tumors between the skip (+) and the skip (-) N2 groups. In the skip (+) group, mediastinal node metastasis was found in only one region (level 1) in 30 patients (90.9%) and in two regions (level 2) in 3 (9.1%), whereas 28 patients (36.4%) from the skip (-) group revealed mediastinal metastasis at two or three regions (level 2 or 3). The overall survival rate at 5 years after operation was 35% in the skip (+) group and 12.7% in the skip (-) group (p = 0.054). This favorable clinical outcome in the skip (+) group could be explained partially by the higher proportion of patients with level 1 metastases. Furthermore, regarding patients with level 1 disease, the skip (+) group tended to have a better prognosis than the skip (-) group (p = 0.096).
Conclusions. These results suggest that patients with skip mediastinal lymph node metastases represent a unique subgroup of N2 disease.
This article has been cited by other articles:
![]() |
P. Misthos, E. Sepsas, J. Kokotsakis, I. Skottis, and A. Lioulias The Significance of One-Station N2 Disease in the Prognosis of Patients With Nonsmall-Cell Lung Cancer Ann. Thorac. Surg., November 1, 2008; 86(5): 1626 - 1630. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mansour, E. A. Kochetkova, N. Santelmo, X. Ducrocq, E. Quoix, J.-M. Wihlm, and G. Massard Persistent n2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy. Ann. Thorac. Surg., July 1, 2008; 86(1): 228 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Minamiya, M. Ito, Y. Hosono, H. Kawai, H. Saito, Y. Katayose, S. Motoyama, and J.-i. Ogawa Subpleural injection of tracer improves detection of mediastinal sentinel lymph nodes in non-small cell lung cancer Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 770 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Whitson, S. S. Groth, and M. A. Maddaus Surgical Assessment and Intraoperative Management of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer Ann. Thorac. Surg., September 1, 2007; 84(3): 1059 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Riquet, P. Bagan, J. Assouad, C. Foucault, and C. Danel Reply. Ann. Thorac. Surg., May 1, 2006; 81(5): 1947 - 1948. [Full Text] [PDF] |
||||
![]() |
Y. Ohta, Y. Shimizu, H. Minato, I. Matsumoto, M. Oda, and G. Watanabe Results of Initial Operations in Non-Small Cell Lung Cancer Patients With Single-Level N2 Disease Ann. Thorac. Surg., February 1, 2006; 81(2): 427 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Casali, A. Stefani, P. Natali, G. Rossi, and U. Morandi Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 33 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Riquet, J. Assouad, P. Bagan, C. Foucault, F. Le Pimpec Barthes, A. Dujon, and C. Danel Skip Mediastinal Lymph Node Metastasis and Lung Cancer: A Particular N2 Subgroup With a Better Prognosis Ann. Thorac. Surg., January 1, 2005; 79(1): 225 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Soltesz, S. Kim, R. G. Laurence, A. M. DeGrand, C. P. Parungo, D. M. Dor, L. H. Cohn, M. G. Bawendi, J. V. Frangioni, and T. Mihaljevic Intraoperative Sentinel Lymph Node Mapping of the Lung Using Near-Infrared Fluorescent Quantum Dots Ann. Thorac. Surg., January 1, 2005; 79(1): 269 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Keller, M. G. Vangel, H. Wagner, J. H. Schiller, A. Herskovic, R. Komaki, R. S. Marks, M. C. Perry, R. B. Livingston, and D. H. Johnson Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 130 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tanaka, K. Takenaka, H. Oyanagi, T. Fujinaga, Y. Otake, K. Yanagihara, H. Ito, and H. Wada Skip mediastinal nodal metastases in non-small cell lung cancer Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 1114 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Misthos, E. Sepsas, K. Athanassiadi, S. Kakaris, and I. Skottis Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 502 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tomita, Y. Matsuzaki, M. Edagawa, T. Shimizu, M. Hara, and T. Onitsuka Lack of prognostic significance of tumor angiogenesis in resected pN2 non-small cell lung cancer Interactive CardioVascular and Thoracic Surgery, June 1, 2003; 2(2): 201 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M.A. Melfi, A. Chella, G. F. Menconi, F. Givigliano, G. Boni, G. Mariani, P. Sbragia, and C. A. Angeletti Intraoperative radioguided sentinel lymph node biopsy in non-small cell lung cancer Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 214 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Schmidt, E. A. Woltering, W. R. Webb, O. M. Garcia, J. E. Cohen, and M. H. Rozans Sentinel nodal assessment in patients with carcinoma of the lung Ann. Thorac. Surg., September 1, 2002; 74(3): 870 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Liptay Commentary on sentinel lymph node identification with technetium-99m tin colloid in non-small cell lung cancer J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 428 - 430. [Full Text] [PDF] |
||||
![]() |
M. J. Liptay, S. C. Grondin, W. A. Fry, C. Pozdol, D. Carson, C. Knop, G. A. Masters, R. M. Perlman, and W. Watkin Intraoperative Sentinel Lymph Node Mapping in Non-Small-Cell Lung Cancer Improves Detection of Micrometastases J. Clin. Oncol., April 15, 2002; 20(8): 1984 - 1988. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Hosch, N. H. Stoecklein, U. Pichlmeier, A. Rehders, P. Scheunemann, A. Niendorf, W. T. Knoefel, and J. R. Izbicki Esophageal Cancer: The Mode of Lymphatic Tumor Cell Spread and Its Prognostic Significance J. Clin. Oncol., April 1, 2001; 19(7): 1970 - 1975. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Liptay, G. A. Masters, D. J. Winchester, B. L. Edelman, B. J. Garrido, T. R. Hirschtritt, R. M. Perlman, and W. A. Fry Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer Ann. Thorac. Surg., August 1, 2000; 70(2): 384 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yano, Y. Fukuyama, H. Yokoyama, S. Kuninaka, Y. Terazaki, T. Uehara, H. Asoh, and Y. Ichinose Long-term survivors with pN2 non-small cell lung cancer after a complete resection with a systematic mediastinal node dissection Eur. J. Cardiothorac. Surg., August 1, 1999; 14(2): 152 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Little, A. DeHoyos, D. M. Kirgan, T. R. Arcomano, and K. D. Murray INTRAOPERATIVE LYMPHATIC MAPPING FOR NON-SMALL CELL LUNG CANCER: THE SENTINEL NODE TECHNIQUE J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 220 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. M. Chan, MB, U. Pastorino, MD, and P. Goldstraw, FRCS SYSTEMATIC NODAL DISSECTION IN THE INTRATHORACIC STAGING OF PATIENTS WITH NON-SMALL CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 246 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, N. Tsubota, M. Yoshimura, and Y. Miyamoto PROPOSAL FOR REASONABLE MEDIASTINAL LYMPHADENECTOMY IN BRONCHOGENIC CARCINOMAS: ROLE OF SUBCARINAL NODES IN SELECTIVE DISSECTION J. Thorac. Cardiovasc. Surg., December 1, 1998; 116(6): 949 - 953. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |